miR-10a是调节高级别膀胱癌增殖和侵袭的肿瘤抑制因子吗?

IF 4.1 4区 医学 Q3 ONCOLOGY
Oncology Research Pub Date : 2025-05-29 eCollection Date: 2025-01-01 DOI:10.32604/or.2025.055306
THAINá Rodrigues, PATRíCIA Candido, Feres Camargo Maluf, Poliana ROMãO, Carolina Mie Mioshi, Vanessa Ribeiro GUIMARãES, Juliana Alves DE Camargo, Karina Serafim DA Silva, Gabriel Arantes Dos Santos, Iran Amorim Silva, Katia Ramos Moreira Leite, William C Nahas, Sabrina T Reis, Ruan Pimenta, Nayara Izabel Viana
{"title":"miR-10a是调节高级别膀胱癌增殖和侵袭的肿瘤抑制因子吗?","authors":"THAINá Rodrigues, PATRíCIA Candido, Feres Camargo Maluf, Poliana ROMãO, Carolina Mie Mioshi, Vanessa Ribeiro GUIMARãES, Juliana Alves DE Camargo, Karina Serafim DA Silva, Gabriel Arantes Dos Santos, Iran Amorim Silva, Katia Ramos Moreira Leite, William C Nahas, Sabrina T Reis, Ruan Pimenta, Nayara Izabel Viana","doi":"10.32604/or.2025.055306","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Bladder Cancer (BC) is one of the most commonly diagnosed malignancies worldwide, with high rates of mortality and morbidity. It can be classified as non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC), with radical cystectomy being the treatment for MIBC, which significantly reduces quality of life. MicroRNAs (miRs) act as critical genetic regulators, with both oncogenic and tumor-suppressive roles. MiR-10a is described as a tumor suppressor in various neoplasms, but its role in BC is controversial. This study aims to assess the activity of miR-10a in cellular invasion and proliferation in two distinct BC cell lines.</p><p><strong>Methods: </strong>The study used high-grade T24 and low-grade RT4 bladder cell lines. Cells were transfected with miR-10a mimic or a non-targeting control. Transfection efficiency was validated by qPCR. Cell proliferation was cultured for 10-14 days. Cell migration and invasion were evaluated using Matrigel. All assays were conducted in triplicate.</p><p><strong>Results: </strong>The T24 cells transfected with miR-10a presented decreased cellular proliferation and invasion compared to the Scramble (<i>p</i> = 0.0481 and <i>p</i> < 0.0001, respectively). In the RT4 cell line, there was only a significant reduction in cellular proliferation after miR-10a transfection (<i>p</i> = 0.0029). <b>Conclusions:</b> Our findings suggest that miR-10a has a tumoral suppressor role in BC, demonstrating higher efficacy in high-grade cells.</p>","PeriodicalId":19537,"journal":{"name":"Oncology Research","volume":"33 6","pages":"1377-1382"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144657/pdf/","citationCount":"0","resultStr":"{\"title\":\"Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?\",\"authors\":\"THAINá Rodrigues, PATRíCIA Candido, Feres Camargo Maluf, Poliana ROMãO, Carolina Mie Mioshi, Vanessa Ribeiro GUIMARãES, Juliana Alves DE Camargo, Karina Serafim DA Silva, Gabriel Arantes Dos Santos, Iran Amorim Silva, Katia Ramos Moreira Leite, William C Nahas, Sabrina T Reis, Ruan Pimenta, Nayara Izabel Viana\",\"doi\":\"10.32604/or.2025.055306\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>Bladder Cancer (BC) is one of the most commonly diagnosed malignancies worldwide, with high rates of mortality and morbidity. It can be classified as non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC), with radical cystectomy being the treatment for MIBC, which significantly reduces quality of life. MicroRNAs (miRs) act as critical genetic regulators, with both oncogenic and tumor-suppressive roles. MiR-10a is described as a tumor suppressor in various neoplasms, but its role in BC is controversial. This study aims to assess the activity of miR-10a in cellular invasion and proliferation in two distinct BC cell lines.</p><p><strong>Methods: </strong>The study used high-grade T24 and low-grade RT4 bladder cell lines. Cells were transfected with miR-10a mimic or a non-targeting control. Transfection efficiency was validated by qPCR. Cell proliferation was cultured for 10-14 days. Cell migration and invasion were evaluated using Matrigel. All assays were conducted in triplicate.</p><p><strong>Results: </strong>The T24 cells transfected with miR-10a presented decreased cellular proliferation and invasion compared to the Scramble (<i>p</i> = 0.0481 and <i>p</i> < 0.0001, respectively). In the RT4 cell line, there was only a significant reduction in cellular proliferation after miR-10a transfection (<i>p</i> = 0.0029). <b>Conclusions:</b> Our findings suggest that miR-10a has a tumoral suppressor role in BC, demonstrating higher efficacy in high-grade cells.</p>\",\"PeriodicalId\":19537,\"journal\":{\"name\":\"Oncology Research\",\"volume\":\"33 6\",\"pages\":\"1377-1382\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144657/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.32604/or.2025.055306\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.32604/or.2025.055306","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:膀胱癌(BC)是世界范围内最常见的恶性肿瘤之一,具有很高的死亡率和发病率。可分为非肌性浸润性膀胱癌(NMIBC)和肌性浸润性膀胱癌(MIBC)两种,MIBC的治疗方法为根治性膀胱切除术,显著降低了患者的生活质量。MicroRNAs (miRs)作为重要的遗传调控因子,具有致癌和抑制肿瘤的作用。MiR-10a被描述为多种肿瘤中的肿瘤抑制因子,但其在BC中的作用存在争议。本研究旨在评估miR-10a在两种不同的BC细胞系中细胞侵袭和增殖的活性。方法:采用高级别T24膀胱细胞系和低级别RT4膀胱细胞系。用miR-10a模拟物或非靶向对照转染细胞。通过qPCR验证转染效率。细胞增殖培养10 ~ 14 d。采用Matrigel软件评价细胞迁移和侵袭情况。所有的测定都是一式三份。结果:转染miR-10a的T24细胞与Scramble相比,细胞增殖和侵袭能力下降(p = 0.0481, p < 0.0001)。在RT4细胞系中,转染miR-10a后,细胞增殖仅显著降低(p = 0.0029)。结论:我们的研究结果表明,miR-10a在BC中具有肿瘤抑制作用,在高级细胞中表现出更高的疗效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?

Objectives: Bladder Cancer (BC) is one of the most commonly diagnosed malignancies worldwide, with high rates of mortality and morbidity. It can be classified as non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC), with radical cystectomy being the treatment for MIBC, which significantly reduces quality of life. MicroRNAs (miRs) act as critical genetic regulators, with both oncogenic and tumor-suppressive roles. MiR-10a is described as a tumor suppressor in various neoplasms, but its role in BC is controversial. This study aims to assess the activity of miR-10a in cellular invasion and proliferation in two distinct BC cell lines.

Methods: The study used high-grade T24 and low-grade RT4 bladder cell lines. Cells were transfected with miR-10a mimic or a non-targeting control. Transfection efficiency was validated by qPCR. Cell proliferation was cultured for 10-14 days. Cell migration and invasion were evaluated using Matrigel. All assays were conducted in triplicate.

Results: The T24 cells transfected with miR-10a presented decreased cellular proliferation and invasion compared to the Scramble (p = 0.0481 and p < 0.0001, respectively). In the RT4 cell line, there was only a significant reduction in cellular proliferation after miR-10a transfection (p = 0.0029). Conclusions: Our findings suggest that miR-10a has a tumoral suppressor role in BC, demonstrating higher efficacy in high-grade cells.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Oncology Research
Oncology Research 医学-肿瘤学
CiteScore
4.40
自引率
0.00%
发文量
56
审稿时长
3 months
期刊介绍: Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信